- Case Report
- Open Access
Peripheral nerve injury with Nexplanon removal: case report and review of the literature
Contraception and Reproductive Medicine volume 3, Article number: 15 (2018)
Implantable devices offer convenient, long-acting, and reversible contraception. Injury to the peripheral nerves and blood vessels have been reported as rare complications of implantation and extraction.
We present a case of ulnar nerve injury in a 21-year-old woman from attempted in-office removal of a deeply implanted Nexplanon® device. The injury resulted in an ulnar nerve palsy requiring surgical exploration, neuroma excision, and sural nerve cable grafting.
In-office attempts to remove contraceptive implants that are deep or have migrated can cause iatrogenic nerve injury. Devices that are non-palpable, deep, or migrated should be imaged before formal surgical exploration and removal. Any patient with neurologic symptoms after placement or after attempted removal requires prompt diagnosis and referral to a peripheral nerve surgeon.
Subdermal contraceptive implants, such as the Nexplanon® (Merck, Kenilworth, NJ), are a popular form of long-acting, reversible contraception. Insertion and removal procedures are designed to be safely performed in the outpatient setting with local anesthetic. However, serious complications, including neurovascular injury, can occur [1,2,3,4,5,6]. These complications were more commonly reported with older devices, especially if they were placed deeply or if they migrated proximally. Multiple case reports have described implant-related injuries to the median [2, 3], ulnar [4, 5], and medial antebrachial cutaneous nerves . These reports prompted device modifications and technique adjustments.
Due to safety concerns, the Food and Drug Administration mandated that healthcare providers undergo training and certification before using the Nexplanon® in practice [7, 8]. Current training recommends the Nexplanon® be placed subdermal and “at the inner side of the non-dominant upper arm about 8-10 cm (3-4 inches) above the medial epicondyle of the humerus, avoiding the sulcus (groove) between the biceps and triceps muscles” [9, 10]. Some providers use a different placement site, over the triceps muscle, to place the implant even further away from neurovascular structures of the medial arm, located between the triceps and biceps . To help guard against deep placement, the proper technique involves insertion at an angle of less than 30° . Furthermore, the newly added plastic barrier over the insertion needle is designed to guide the Nexplanon® into the superficial layer below the dermis [12, 13].
Proper removal technique is also important in avoiding complications. The safest method of extraction involves definitive palpation of the device immediately before attempting in-office removal . Devices may be non-palpable because they were placed deeply or because they have migrated. Contraceptive devices placed in the arm have migrated as far as the shoulder, axilla, chest wall, and even the pulmonary arteries . From the hand surgeon’s perspective, implant migration is a well-documented complication and is known to occur even when an implant is originally placed into solid bone . Merck acknowledges that Nexplanon® migration is a risk and recommends that if the device is not palpable at the time of planned removal, X-ray, computed tomography (CT), ultrasound, or even magnetic resonance imaging (MRI) can be used to aid location .
Even with the mandated training, technique guidelines, and design improvements, serious complications can still arise. Merck maintains a database of deep implants and complex removals . The complication we present is the first case reported of ulnar nerve injury during attempted in-office removal of a deep Nexplanon®. The patient required formal surgical exploration for implant removal, resection of an ulnar nerve traumatic neuroma, and reconstruction of the ulnar nerve.
A 21-year-old woman presented to our hand and peripheral nerve clinic 4 months after attempted Nexplanon® removal from her left arm. The patient reported that neither she, nor her nurse practitioner (NP), was confidently able to feel the Nexplanon® before the attempted removal. Imaging studies to confirm location of the Nexplanon® were not performed. The patient remembered a small incision being made at the site of insertion after local anesthetic was injected. The provider was not immediately able to find the Nexplanon®, but after exploring the local area, did grasp another structure in her arm. The patient felt an “electric shock” sensation that radiated down to her medial elbow as the NP pulled. No further attempts to remove the Nexplanon® were undertaken.
Immediately after the removal attempt, the patient had complete numbness in her small and ring fingers. She returned for follow up to her NP. As months progressed, the numbness did not improve, and she began to notice wasting of her hand muscles and weakness in her grip. At almost 4 months after the attempted removal, her NP ordered a nerve conduction study which showed 50% loss of ulnar nerve function.
On presentation to the office, she had classic signs of severe, chronic ulnar nerve injury: wasting of the ulnar nerve-innervated intrinsic muscles of the hand, a claw position of the ring and small fingers, and dense numbness in an ulnar sensory nerve distribution (Fig. 1). On examination of her arm, there was a well-healed incision with surrounding scar tissue from the extraction attempt. The Nexplanon® was not palpable. X-rays showed the radio-opaque Nexplanon® at the junction of the proximal and middle thirds of the humeral shaft with the most distal end 16.5 cm proximal to the medial epicondyle (Fig. 2).
Given the patient’s history, physical exam, and nerve tests, timely surgical intervention was recommended. In the OR, the upper extremity surgery team used fluoroscopy to mark the location of the Nexplanon® (Fig. 3). On surgical exploration, the Nexplanon® was found deep to the brachial fascia of the arm and in direct contact with the ulnar nerve. Less than five millimeters away was the undamaged brachial artery--the main blood supply to the arm, forearm, and hand. The Nexplanon® was removed using microsurgical instruments.
Because of the patient’s dense ulnar nerve palsy, the ulnar nerve at the level of the attempted extraction was also explored. Dissection showed that the ulnar nerve had been severely damaged at this level (Fig. 4). Nerve injury can take many forms; this patient’s injury was a neuroma-in-continuity whereby the ulnar nerve was still one solid, longitudinal structure, but contained an abnormal portion, filled with scar tissue and damaged nerve fascicles that could not conduct electrical signal. The surgical team confirmed the neuroma’s inability to conduct via intra-operative electrical stimulation. The appearance of her neuroma-in-continuity was classic: the neuroma was fusiform in shape and felt thickened and hard, unlike the proximal and distal, soft and pliable uninjured nerve (Fig. 4a).
The upper extremity surgeons treated the neuroma-in- continuity with microsurgical resection, followed by reconstruction. After the damaged, scarred nerve was removed, there was a 3 cm gap between healthy sections of the ulnar nerve (Fig. 4b). The patient retained three uninjured nerve fascicles which made up less than 20% of the normal diameter of the nerve. The healthy fascicles were dissected free and preserved (Fig. 5b). To bridge the nerve gap, the patient’s sural nerve was harvested from her lower leg, cut into 3 cm long segments and bundled together to recreate the caliber and fascicles of the resected ulnar nerve (Fig. 5). This cabled sural nerve autograft was sutured into place using a surgical microscope and 9–0 Nylon sutures.
At 7 months after nerve reconstruction, the patient had weak grade 2/5 function of ulnar innervated muscles. She still had dense numbness in an ulnar nerve distribution. She did have an advancing Tinel’s sign on physical exam and reported intermittent paresthesias in an ulnar nerve distribution in her hand.
Discussion and conclusions
The presented case is an example of an uncommon, but serious complication from implantable contraception. Peripheral nerve injury from any cause often carries a poor prognosis and causes significant disability for patients. For this patient, both deep implantation and in-office removal of a non-palpable device contributed to the iatrogenic nerve injury. The medial arm is a dense anatomic area where precise device implantation and extraction are required to maximize patient safety. Our patient’s limited recover 7 months after nerve reconstruction is unfortunately not uncommon: the prognosis for recovery after repair or reconstruction is particularly poor for the ulnar nerve [16, 17]. Prompt diagnosis and treatment is crucial to preserve treatment options and maximize a patient’s outcome. It is also important to keep in mind that delayed or incomplete treatment of nerve injuries, particularly of iatrogenic nerve injuries, can result in significant liability [18, 19].
Peripheral nerves of the arm can be at risk with either insertion or extraction of a contraceptive implant into the arm. The majority of cases have been described with older implantable devices. Specifically, Norplant has been reported to cause transient paresthesias that resolve with removal [20, 21]. Norplant removal has be associated with ulnar nerve injury and with significant scar tissue around the ulnar nerve causing nerve compression with motor and sensory symptoms . Implanon® (Organon International INC, Roseland, NJ) insertion and removal has been linked to sensory-only medial antebrachial cutaneous nerve injury, medial cutaneous nerve of the forearm injury, and transient ulnar nerve sensory deficit after device removal [6, 8, 23]. And, as in our case, the currently available Nexplanon® with it’s updated delivery system and specific insertion and removal technique has been associated with median nerve injury in two cases . Other recently reported cases do not mention the specific device used, but describe injury to the median nerve, medial antebrachial cutaneous, and ulnar nerves in a single patient and structural injury to the ulnar nerve in another patient [4, 5].
We emphatically agree with the current manufacturer recommendations: insertion should avoid the sulcus between the biceps and triceps where the median nerve, ulnar nerve, brachial artery and vein are located . Furthermore, our case strongly supports the manufacturer’s recommendation that extraction should not be attempted without knowing the exact location of the device . It is the senior author’s opinion that in-office placement and removal should be performed or directly supervised by an experienced physician who has undergone the appropriate implant-based training.
Since deep implantation and migration are possible, imaging studies should be used to precisely localize migrated or non-palpable devices before removal. In one paper describing operative removal of 28 implantable contraceptive devices, 30% of implants had migrated from the insertion site with 37% lying intramuscular and 11% lying in the neurovascular sheath . Imaging studies should also be done for any patient who develops neurologic symptoms. X-ray, CT, MRI, and ultrasound can all be used to precisely identify an implant’s location. X-ray and ultrasound are both inexpensive, accessible, and non-invasive imaging modalities. While ultrasound offers a zero-radiation technique for localization, X-ray machines and radiologist interpretation are widely available and relatively inexpensive. Although X-ray does involve ionizing radiation, two standard views of the humerus only exposes a patient to 0.001 mSv of radiation . This is the same amount of radiation an average US habitant sees by simply being exposed to our environment for 3 h .
Multidisciplinary care involving family planning practitioners and peripheral nerve surgeons for complex removal improves patient care and optimizes safety . Nerve surgeons can have a hand surgery, orthopaedic surgery, plastic surgery, or neurosurgery background. Symptoms that can indicate an iatrogenic nerve injury at the time of placement or removal include electric or shock-like pain, numbness, or weakness in the distribution of a peripheral nerve. Physical exam findings can include decreased sensation to touch and hand or forearm weakness. Late signs of untreated nerve injury include visible muscle wasting or abnormal posturing such as our patient’s ulnar claw hand.
Prompt referral to a peripheral nerve surgeon is crucial because the motor end plates and end target muscles irreversibly degenerate without nerve input . After nerve repair or grafting, nerves regenerate at a rate of approximately 1 mm per day . As a rule of thumb, if the newly advancing axons do not reach the muscle by 12 months after injury, the damage is permanent and no meaningful functional recovery is made .
Even though there are surgical options for timely nerve repair and reconstruction, normal sensation and strength almost never return. Loss of ulnar nerve function is devastating for patients as the ulnar nerve is responsible for extrinsic and intrinsic hand muscles, as well as crucial hand sensation . Sural nerve autograft is the current gold standard in major peripheral nerve reconstruction. Taking the sensory sural nerve from the leg universally results in lateral foot numbness . In addition, a small percentage of patients have lasting neuropathic pain from this iatrogenic sural nerve injury .
In conclusion, Nexplanon® related major peripheral nerve injuries are an uncommon but possible complication. We recommend documenting the precise location of the implant with careful physical exam after insertion and before extraction. If a patient develops nerve symptoms in the setting of a non-palpable implant or migrated device, imaging and prompt referral to a peripheral nerve and upper extremity surgeon is strongly recommended. Experienced referral centers can be located by contacting the manufacturer.
Belyea C, Ernat J, Gumboc R. Removal of a contraceptive implant from the brachial neurovascular sheath. J Hand Surg [Am]. 2017;42:e115–7.
Christensen JM, Caggiano NM, Giladi AM, Iorio ML. Median nerve injury after removal of subdermal implantable contraceptive. Hand (N Y). 2017; https://doi.org/10.1177/1558944717744335.
Gillies R, Scougall P, Nicklin S. Etonogestrel implants - case studies of median nerve injury following removal. Aust Fam Physician. 2011;40:799–800.
O’Grady EE, Power DM. Ulnar nerve injury on removal of a contraceptive implant. Practitioner. 2016;260:21–4.
Restrepo CE, Spinner RJ. Major nerve injury after contraceptive implant removal: case illustration. J Neurosurg. 2016;124:188–9.
Wechselberger G, Wolfram D, Pulzl P, Soelder E, Schoeller T. Nerve injury caused by removal of an implantable hormonal contraceptive. Am J Obstet Gynecol. 2006;195:323–6.
Creinin MD, Kaunitz AM, Darney PD, Schwartz L, Hampton T, Gordon K, Rakers H. The US estrogestrel implant mandatory clinical training and active monitoring programs: 6-year experience. Contraception. 2017;95:205–10.
Vidin E, Garbin O, Rodriguez B, Favre R, Bettahar-Lebugle K. Removal of estogestrel contraceptive implants in the operating theater: report on 28 cases. Contraception. 2007;76:35–9.
Kang S, Niak A, Gada N, Brinker A, Jones SC. Etonogestrel implant migration to the vasculature, chest wall, and distant body sites: cases from a pharmacovigilance database. Contraception. 2017;96:439–45.
Merck. Nexplanon prescribing information. New Jersey: Whitehouse Station; 2017. p. 1–23.
Mommers E, Blum GF, Gent TG, Peters KP, Sordal TS, Marintcheva-Petrova M. Nexplanon, a radiopaque etonogestrel implant in combination with a next-generation applicator: 3 year results of a noncomparative multicenter trial. Am J Obstet Gynecol. 2012;207(388):e381–6.
Bragg TW, Jose RM, Bland JW, Matthews RN, Srivastava S. Implantable contraceptive devices: primum non nocere. J Fam Plann Reprod Health Care. 2006;32:190–2.
Mansour D. Nexplanon: what Implanon did next. J Fam Plann Reprod Health Care. 2010;36:187–9.
Park SY, Kang JW, Yang DH, Lim TH. Intracardiac migration of a Kirschner wire: case report and literature review. Int J Card Imaging. 2011;27:85–8.
Pillai M, Gazet AC, Griffiths M. Continuing need for and provision of a service for non-standard implant removal. J Fam Plann Reprod Health Care. 2014;40:126–32.
He B, Zhu Z, Zhu Q, Zhou X, Zheng C, Li P, Zhu S, Zhu J. Factors predicting sensory and motor recovery in the repair of upper limb peripheral nerve injuries. Neural Regen Res. 2014;2014(6)
Ruijs AC, Jaquet JB, Kalmijn S, Giele H, Sovius SE. Median and ulnar nerve injuries: a meta-analysis of predictors of motor and sensory recovery after modern microsurgical nerve repair. Plast Reconstr Surg. 2005;116:484–94.
Rowlands S. Legal aspects of contraceptive implants. J Fam Plann Reprod Health Care. 2010;36:243–8.
Rowlands S. Nerve injuries related to etonogestrel implant. Contraception. 2013;88:431.
Chang A, Edlich RF, Himel NH. Local reactions at the insertion site of the Norplant contraceptive system. J Long-Term Eff Med Implants. 1993;3:305–12.
Hueston WJ, Locke KT. Norplant neuropathy: peripheral neurologic symptoms associated with subdermal contraceptive implants. J Fam Pract. 1995;40:184–6.
Marin R, McMillian D. Ulnar neuropathy associated with subdermal contraceptive implant. South Med J. 1998;91:875–8.
Brown M, Britton J. Neuropathy associated with etonogestrel implant insertion. Contraception. 2012;86:591–3.
Radiological Society of North America Inc. Radiology Info for Patients. 2018 2/20/18]; Available from: https://www.radiologyinfo.org/en/pdf/safety-xray.pdf.
Odom EB, Eisenberg DL, Fox IK. Difficult removal of subdermal contraceptive implants: a multidisciplinary approach involving a peripheral nerve expert. Contraception. 2017;96:89–95.
Birch R, Quick T, Nerve injury and repair in Green’s Operative Hand Surgery 2017: Philadelphia.
Kim S, Moran SL. Ulnar Nerve Repair. In: Slutsky D, editor. Upper extremity nerve repair - tips and techniques: a master skills publication. Rosemont: ASSH; 2008. p. 113–24.
No funding was received in the collection, analysis, and interpretation of data or in the writing of the manuscript.
RL assisted in operative and perioperative care of the patient. RL was a major contributor in writing the manuscript, reviewing the literature, and creating figs. MH was a major contributor in writing the manuscript and reviewing the literature. HL assisted in operative care of the patient. He provided clinical images and contributed to writing and editing the manuscript. MS was the attending physician for the patient for the patient’s perioperative and operative care. He contributed to manuscript outline and editing. All authors read, edited, and approved the final manuscript.
Ethics approval and consent to participate
No formal ethics approval was sought for this retrospective case report. Single patient case reports are exempted from review by the Institutional Review Board.
Consent for publication
The patient provided verbal and written consent using the University of Southern California institutional consent forms to have her case (including non-identifying clinical images) published.
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Lefebvre, R., Hom, M., Leland, H. et al. Peripheral nerve injury with Nexplanon removal: case report and review of the literature. Contracept Reprod Med 3, 15 (2018). https://doi.org/10.1186/s40834-018-0070-0
- Contraception complications
- Iatrogenic peripheral nerve injury
- Implant migration